<DOC>
	<DOC>NCT00327587</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of the various combinations of valsartan, HCTZ, and amlodipine in patients with moderate to severe hypertension.</brief_summary>
	<brief_title>8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Diagnosis of moderate to severe hypertension (MSDBP ≥ 100 mmHg and &lt; 120 mmHg, MSSBP ≥ 145 mmHg and &lt; 200 mmHg). Patients on two or more antihypertensive drugs with MSSBP ≥ 180 mmHg and/or MSDBP ≥ 110 mmHg at Visit 1. Patients on three or more antihypertensive drugs with MSDBP ≥ 90 mmHg and &lt; 110 mmHg, and/or MSSBP ≥ 140 mmHg and &lt; 180 mmHg at Visit 1. Patients on four or more antihypertensive drugs at Visit 1. Arm circumference &gt; 42 cm for patients participating in ABPM. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>valsartan</keyword>
	<keyword>amlodipine</keyword>
	<keyword>HCTZ</keyword>
</DOC>